Comment on CMS-2026-1256-0002

Summary: The American College of Cardiology (ACC) provides a mixed response to the proposed rule, expressing support for several MS-DRG updates, mortality measure modernizations, and interoperability streamlining. However, the organization strongly opposes the inclusion of medications in the electronic prior authorization measure and urges CMS to discard or delay the repeal of the alternative pathway for NTAP due to concerns over innovation and insufficient notice.